Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Workday
WDAY
|
+$415M |
| 2 |
Atlassian
TEAM
|
+$397M |
| 3 |
TJX Companies
TJX
|
+$266M |
| 4 |
Corteva
CTVA
|
+$199M |
| 5 |
JPMorgan Chase
JPM
|
+$163M |
Top Sells
| 1 |
Apple
AAPL
|
+$2.44B |
| 2 |
Microsoft
MSFT
|
+$1.41B |
| 3 |
Amazon
AMZN
|
+$657M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$564M |
| 5 |
Meta Platforms (Facebook)
META
|
+$537M |
Sector Composition
| 1 | Technology | 30.37% |
| 2 | Healthcare | 21.1% |
| 3 | Financials | 10.49% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Industrials | 9.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
AMN Healthcare
AMN
$725M
| $3.01M | ﹤0.01% |
27,395
-29,106
| -52% | -$3.19M |
|
|
SHAP
952
DELISTED
Spree Acquisition Corp. 1 Limited
SHAP
| $2.99M | ﹤0.01% |
300,000
| – | – |
|
953
BJs Wholesale Club
BJ
$12.9B
| $2.98M | ﹤0.01% |
47,804
+950
| +2% | +$59.2K |
|
954
National Health Investors
NHI
$3.76B
| $2.98M | ﹤0.01% |
49,134
+9,053
| +23% | +$549K |
|
955
West Pharmaceutical
WST
$18.9B
| $2.95M | ﹤0.01% |
9,741
-678,657
| -99% | -$206M |
|
|
LTC
956
LTC Properties
LTC
$1.68B
| $2.94M | ﹤0.01% |
76,515
-11
| -0% | -$422 |
|
957
Immunic
IMUX
$84.2M
| $2.92M | ﹤0.01% |
843,817
+510,828
| +153% | +$1.76M |
|
|
ANSS
958
DELISTED
Ansys
ANSS
| $2.82M | ﹤0.01% |
11,766
-3,987
| -25% | -$955K |
|
959
Synchrony
SYF
$28.3B
| $2.81M | ﹤0.01% |
101,695
-598,468
| -85% | -$16.5M |
|
960
Watsco
WSO
$16.1B
| $2.76M | ﹤0.01% |
11,570
-7,821
| -40% | -$1.87M |
|
|
BNNR
961
DELISTED
Banner Acquisition Corp. Class A Common Stock
BNNR
| $2.76M | ﹤0.01% |
280,000
+80,000
| +40% | +$789K |
|
962
Zimmer Biomet
ZBH
$20.6B
| $2.76M | ﹤0.01% |
26,236
-120,517
| -82% | -$12.7M |
|
|
ETAC
963
DELISTED
E.Merge Technology Acquisition Corp. Class A Common Stock
ETAC
| $2.75M | ﹤0.01% |
275,363
-26
| -0% | -$260 |
|
964
W.W. Grainger
GWW
$48.5B
| $2.75M | ﹤0.01% |
6,046
-72,562
| -92% | -$33M |
|
965
Diamondback Energy
FANG
$40.1B
| $2.75M | ﹤0.01% |
22,654
-685
| -3% | -$83K |
|
966
Pembina Pipeline
PBA
$22.6B
| $2.73M | ﹤0.01% |
77,515
-19,884
| -20% | -$701K |
|
967
Vulcan Materials
VMC
$39.9B
| $2.71M | ﹤0.01% |
19,084
-8,776
| -32% | -$1.25M |
|
968
Copart
CPRT
$47.3B
| $2.69M | ﹤0.01% |
99,088
-5,686,588
| -98% | -$154M |
|
|
X
969
DELISTED
US Steel
X
| $2.67M | ﹤0.01% |
149,179
+94,848
| +175% | +$1.7M |
|
970
CMS Energy
CMS
$21.5B
| $2.66M | ﹤0.01% |
39,460
-40,990
| -51% | -$2.77M |
|
971
Qualys
QLYS
$4.89B
| $2.65M | ﹤0.01% |
21,034
-12,832
| -38% | -$1.62M |
|
972
Toro Company
TTC
$7.82B
| $2.65M | ﹤0.01% |
34,950
-218,604
| -86% | -$16.6M |
|
|
ASAX
973
DELISTED
Astrea Acquisition Corp. Class A Common Stock
ASAX
| $2.65M | ﹤0.01% |
270,000
| – | – |
|
|
PRFT
974
DELISTED
Perficient Inc
PRFT
| $2.63M | ﹤0.01% |
28,715
+4,700
| +20% | +$431K |
|
975
Brown-Forman Class B
BF.B
$13B
| $2.62M | ﹤0.01% |
37,401
-14,534
| -28% | -$1.02M |
|